Colorado biotech company's shares soaring after getting good news from FDA

Shares in Arca Biopharma Inc. were soaring Tuesday after the Westminster biotech received good news from the U.S. Food and Drug Administration. Arca Biopharma (Nasdaq: ABIO) announced a "positive outcome of (an) end-of-phase 2 meeting with" the FDA regarding Gencaro treatment for atrial fibrillation (AF) patients with heart failure (HF). Arca Biopharma said it anticipates initiating a Phase 3 clinical trial "subject to securing additiona l financing through a strategic partnership and/or additional…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news